CN Patent

CN108863955B — 二苯基吡嗪类化合物或其药学上可接受的盐、异构体及其制备方法和用途

Assigned to Chengdu Easton Biopharmaceuticals Co Ltd · Expires 2021-08-13 · 5y expired

What this patent protects

本发明提供了具有式 结构的二苯基吡嗪类化合物或其药学上可接受的盐、异构体，具有体外抗血小板聚集活性，能够显著降低造模动物的平均肺动脉高压，具有更优的IP受体的激动活性。

USPTO Abstract

本发明提供了具有式 结构的二苯基吡嗪类化合物或其药学上可接受的盐、异构体，具有体外抗血小板聚集活性，能够显著降低造模动物的平均肺动脉高压，具有更优的IP受体的激动活性。

Drugs covered by this patent

Patent Metadata

Patent number
CN108863955B
Jurisdiction
CN
Classification
—
Expires
2021-08-13
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Easton Biopharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.